[Serologic study of experimental cholera polymer antigen diagnosticums]

Area of Science:

• Microbiology
• Immunology
• Diagnostic Development

Background:

• Cholera remains a significant public health concern, necessitating reliable diagnostic tools.
• Development of effective diagnosticums for cholera antigen detection is crucial for disease control.
• Standardization and quality control of diagnostic preparations are essential for accurate results.

Purpose of the Study:

• To evaluate the quality indicators of constructed cholera antigen polymer diagnosticums.
• To assess the suitability of specific cholera vibrio strains as sensitins for diagnosticum development.
• To determine appropriate control sera for validating experimental cholera diagnosticums.

Main Methods:

• Utilized cell lysates from Vibrio cholerae cholerae 1395, V. eltor Ogawa 2044, V. eltor Inaba 13020, and V. cholerae O139 16064 as sensitins.
• Employed a range of specific anti-cholera sera, including patient sera, commercial sera, and experimental sera, for quality evaluation.
• Included heterologous antisera against related enteric pathogens for specificity assessment.

Main Results:

• Diagnosticums incorporating Vibrio cholerae cholerae 1395 and V. cholerae O139 16064 strain sensitins demonstrated favorable quality indicators.
• These findings suggest the potential utility of these specific strains in the future construction of cholera diagnosticums.
• The study identified specific antibody-containing preparations suitable for controlling experimental diagnosticums.

Conclusions:

• Diagnosticums based on V. cholerae cholerae 1395 and V. cholerae O139 16064 sensitins are promising for future development.
• High-titered commercial O1 horse sera, rabbit experimental/commercial sera, and MCA O139 can serve as effective controls.
• These validated controls are particularly important in the absence of human cholera patient sera.